AboutSign In

Akeso

Organization

China-based biopharmaceutical company that developed ivonescimab, a PD-1/VEGF bispecific antibody

2 stories

01
health6d ago

Researchers Present New Cancer Treatment Advances Including Immune Evasion Countermeasures and Chemo Alternatives

9 min read
02
health12d ago

Contested Lung Cancer Drug Shows 34% Reduction in Death Risk in Late-Stage China Trial

7 min read